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Dermal fibrosis, characterized by collagen accumulation, 
is the hallmark of several cutaneous diseases. To examine 
the mechanisms of collagen deposition in fibrotic skin dis-
eases, fibroblast cultures were es tablished from the skin of 
patients with progressive systemic sclerosis, morphea, 
scleredema, famili al cutaneous collagenoma, connective 
tissu e nevi of the collagen type, or keloids; these patients 
serve d as prototypes of fibrotic skin diseases with varying 
clinical features and potentially different etiologic factors. 
Collagen production was assayed by the synthesis of 
[3H] hydroxyproline, and types I and III procollagen mes-
senger RNA (mRNA) levels were determined by dot blot 
hybridiza tions using human type I and type III procollagen-
specific cDNA probes. The collagen production in fibro-
blast cultures from the fibrotic diseases was increased up 
to 6-fold over the controls, and a relatively good correlation 
D ernul fibrosis is the hallmark of several diseases affectin g skin [2-4] . The cutaneous diseases with dermal fibrosis can be cl assified into several distinct categories on the basis of clinical features, associated findin gs, and inheritance (Table I) . For example, 
rhe c u t aneous fibrosis can be part of a generalized connective tissue 
involvement, as in progress ive systemic sclerosis, or it can be 
strictI y localized in the skin , as in morphea. The dermal fibrosis 
can result fro m an immunologic o r metabolic aberration, o r it 
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between the collagen production and type I collagen mRNA 
levels was noted. The type IIIII procollagen mRNA ratio 
in control fibroblast cultures was 5.9 ± 1.6 (mean ± SD). 
The corresponding ratio in keloid cell culture was markedly 
increased, while slightly decreased values were noted in the 
case of morphea and familial cutaneous collagenoma; the 
values in other cultures were with,in the normal range. The 
results suggest that procollagen production in fibroblast 
cultures derived from fibrotic skin diseases refl ects elevated 
levels of the corresponding procollagen mRNA. The in-
creased mRNA abundance, suggesting pretranslational 
control, may result from enhanced transcriptional activity 
of the corresponding gene or alternatively reflects increased 
stability of the mRNA molecule. J Invest D ermatol 88:727-
731, 1987 
ca n be chemically induced. Most fibroti c conditions are acq uired, 
but dermal fibrosis is the major clinical feature in two heritable 
diseases, namely familial cutaneous collagenoma [5] and the SI13-
green patches in tuberous sclerosis [6] (Table I). 
The cutaneous diseases with dermal fibrosis share several his-
topathologic features [7]. The dermis is usuall y thickened with 
the extracellular matrix of th e connective tissue in vadin g areas of 
the subcutaneous adipose tissue. The ex tracellular matrix is pre-
dominantly composed of collagen, which for example in the case 
ofkeloids comprises approximately 60% of the dry weight of the 
tissue [8]. Thus, there is a net increase in the amount of coll agen 
in the lesional skin in fibrotic diseases. Furthermore, particularly 
in the ea rl y stages of the fibrotic process, there is a marked fi-
broblas tic cell infiltrate. 
The excessive accumulation of collagen in the fibrotic skin 
les ions can result from aberrations in collagen metabolism by 
several different mechanisms, as for example , by increased col-
lagen prod uction by fibroblasts, reduced degradation of collagen 
either intra- or extracellularly, o r expansion of fibroblast sub-
populations active in collagen production. Previous studies uti-
lizing cell culture techniques have es tablished that in some fibroti c 
diseases the skin fibroblasts are overproducing collagen. This has 
been shown to be true in cases of progressive systemic sclerosis 
[9-12], morphea [13], and keloids [8, 14,15]. Also, in the case of 
scleroderma, recent studies have sugges ted that the levels of type 
I procollagen messenger RNA (mRNA) are similarly increased 
[16,17] . To explore the mechanisms leading to dermal fibrosis, 
we have examined fibroblas ts derived fro m 6 patients, each with 
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Table I. C lassifi cation of C utaneo us Diseases With 
Dermal Fibrosis 
Scleroderma 
Systemic Scleroderma 
Progressive sys temic sclerosis 
C REST syndrome 
Localized Scleroderma (Morphea) 
Circumscribed morphea 
Linear morphea 
Guttate morphea 
Generalized morphea 
Scleroderma-like Skin C hanges in Systemic Diseases 
Inflammatory Connective T issue Diseases 
Mi xed connective tissue disease 
Features of scleroderm a in lupus erythematosus and 
dermatomyositis 
Eosinophilic fasc iitis 
Metabolic and Immunologic Disorders 
Chronic graft-vs-host disease 
Porph yrias 
Phenylketonuria 
Carcinoid syndrome 
Scleredema with paraproteinemia 
Ju venile-onset diabetes mellitus 
Acromegaly 
Premature Aging Syndromes 
Werner's syndrome 
Chemica lly Induced Dermal Fibrosis 
Drugs 
Bleomycin 
Pentazocine 
C hemi cals 
Polyvinyl chloride 
Si licates 
O rganic solvents 
Contaminated rapeseed oil (toxic o il syndrome) 
Connecti ve Tissue Hamartomas of the Collagen Type 
Inherited 
Familial cutaneous collagenoma 
Shagreen patches in tuberous sclerosis 
Acquired 
Isolated collagenomas 
Eruptive co llagenomas 
Kcloids 
Hypertrophic sca rs 
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indica ted in Tab le II. The primary cultures w ere es tablished from 
biopsy specimens obtained from the lesion al skin. Contro l cul-
tures were established from age-matched no rmal subj ects w ho 
underwent a surg ical procedure for cosm etic reasons. The contro l 
cultures were esta blished from the si te-m atched area of skin . The 
primary cultures w ere passed by trypsini za tion , and the secondary 
cultures were m aintained in Dulbecco's m o dified Eagle's m edium 
(DMEM) under standard tissue culture conditions [20]. 
For collagen analyses, the fibroblast cultures in earl y visual 
confluency were incubated in DMEM supple m ented with 20% 
fetal ca lf serum and 25 ,ug/ ml of ascorbic acid. After a 4-h pre in-
cubation, [JH]pro line (L-[2,3,4,5-JH]proline, 109 C i/ mmol ; 
Amersham) was added and the in cubatio ns were continued for 
18 h . At the end of in cubatio n , the m edium was removed and 
mixed with protease inhibitors to g ive final concentrations o f 10 
mM N a2EDTA, 10 mM N-eth y lm aleimide, and 1 mM ph en y l-
m ethylsulfonyl flu o ride. The cell la yer was rinsed w ith 0.15 M 
NaC l, 50 mM Tris-HC l, pH 7 .5, and the rinse was co mbined 
with the medium fra ction . The cells were scraped w ith a rubbe r 
policem an into 50 mM Tris-HC l, pH 7.5, containin g 1. 0 M N aCI 
and the protease inhibitors indicated .above . The cells w ere ho -
m ogenized with a Teflon- g lass ho m ogenizer at 4°C. Aliquo ts of 
the cell s and m edium were dialyzed against dis tilled water, h y -
drolyzed a t 120°C for 16 h , and assayed for [3H]hydroxyproline 
[21] . Aliquots of the cell homogenates w ere also dia lyzed against 
1 mM Tris-HCl , pH 7.5 , containing 0.15 M N aCl, and assayed 
for cell protein [22]. 
a different type of fibrotic skin disease, for their collagen m etab-
o lism in vitro. These patients serve as prototypes representing 
different phenotypic fo rms of cutaneous fibrosi s. 
For assay of types I and 11/ procolJagen mRN A levels, poly(A) + -
RN A was isolated from the cells by oli go-dT cellulose cllro -
matog raphy, as indicated previously [8,23 ,24]. The recovery of 
the poly(A) + -RN A was determined by a technique utilizing rab-
bit g lo bin mRN A as an internal s tandard 18] . The collagen-specific 
mRNA levels were then d etermined by dot blot hybridiza tions 
utili zing well-characterized human proa l(I), proa2(I), and 
proal(lII) collagen-specific complementary DNA (cDNA) probes 
[25-27]. Hybridiza tion s were perform ed by dotting aliquots of 
poly(A) +-RNA in distilled w ater mixed with an equal volume 
ofa so lu tion containing 3 vol of20 x SSC (0.15 M N aCl, 0.015 
M sodium citrate, pH 6.8) and 2 vol of 37% formaldehyde [28]. 
The sa mples w e re heated at 65°C for 5 min and dotted o n nitro-
cellulose filte rs using a vacuum m anifold (Minifold II , Schleicher 
& Schuell). The nitrocellulose filte rs w ere air dried and hea ted at 
78°C for 90 min in a vacuum oven. The filters were then pre-
hybridized at 42°C in a so lution containing 3 X SSC, 50% form-
amide, 0.1 % sodium dodecyl sulfate (SDS) , 50 ,ug/ ml denatured 
salmon sperm DNA, 0.02% po lyvinyl pyrrolido ne, 0.02% bo-
vine serum albumin , and 0.02% Ficoll [28] . The hybridiza tions 
w ere carried out in the same solutio n containing 10 ng/ml of a 
collagen- specific cDNA, labeled by nick translation with a_J2p_ 
labeled deoxyribonucleotides to a specific activity of approx i-
PATIENTS AND METHODS 
Fibro blas t cultures w ere established from the skin of 6 patients 
with derm al fibrosis. The clinical features of these patients are 
Table II. C linica l Features of the Patients With Dermal Fibrosis 
Patient 
No. 
2 
3 
4 
5 
6 
Diagnosis 
Progressive sys temic 
sclerosis 
Morphea 
Scleredema 
Familia l cutaneous 
collagenoma 
Connective tissue nevi 
of the collagen type 
Keloid 
Age 
(years)/Sex 
56/M 
141 M 
49/F 
42/M 
14 / F 
21/F 
Duration of 
Disease 
6 months 
6 months 
1 month 
26 years 
13 yea rs 
6 months 
C linical Features 
Rapid ly progressing induration and thickening of the skin. 
Severe in volvement of the lungs and esophagus. Patient 
died 1 year after onse t of the disease. 
Indurated plaque on the trunk surrounded by 
inflammation. The lesion enlarging progressively. 
Ra pidl y developing thickening and induration of the skin 
on the face and neck. A circulating paraprotein of IgM 
type was detected by serum immunoelectrophoresis 
11 81· 
Multiple asymptomatic dermal nodules on the upper 
trunk . Family history consistent with autosomal 
dominant inheritance [51 . 
Cerebriform connective tiss lle nevi over the plantar 
surfaces of both feet. No family history of a similar 
condition 11 91. 
Rapidly growing lesion on the ea rlobe. 
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ma tel y 5 X 108 cpml J.Lg [29]. The hybridiza tions were carried 
l out for 18 h at 42°C. The filters were washed successively in 500 
ml of 2 X SSC at 24°C, and then 1 X SSC, 0.5 X SSC + 0. 1 % 
SDS , a nd 0.25 x SSC , all at 65°C , 10 min each . The stringency 
of the hybridiza tions and the w ashing conditions preclude any 
cross-hybridization between type I and type III procoUagenmRNAs 
wh e n t ype-specifi c probes are used , as detected by N orthern blo t 
ana lyses [30]. The fi lters were dried and exposed to x-ray film s 
(Dupo nt, C ronex) in cassettes equipped with intensifying screens. 
The rnRNA-[32P]cDNA hybrids w ere visualized by auto radiog-
ra phy and qu antitated by liquid scintillatio n countin g. The results 
wer e corrected fo r the specifi c ac tivity and leng th o f the cON A 
probes, as well as fo r chain composition of type I and III pro-
collagens. 
Sta ti stical eva luations w ere performed by Aspin-Welch two-
sample tes t o f m eans. 
RES ULTS 
Pro du c tion of proco ll agen , m easured as synth es is o f 
[3H]hydroxy proline in cultures in cubated with r3Hlproline, was 
incr eased in all 6 cell lines studied (Tab le III). The hig hest in crease, 
approximately 6-fold , was no ted in fibro blas t cultures es tablished 
fro m patient no. 2 with morphea, while the values in o ther cell 
cultures were in creased by 1. 8- to 3.0-fo ld (T able III) . 
To exa min e the mechanism s o f in creased proco llagen produ c-
tion in these cultures, the levels o f ty pes I and type III procollagen 
mRNAs we re measured . The ty pe 1 procollagen mRNA levels, 
de te rmined by hybridiza tions with proa 2(1) collagen cDNA , in 
the c ulture fro m fib ro ti c skin diseases w ere 16.7 ± 3. 1 cpm / ng 
pol y (A) + -RNA (m can ± SE M) , and the correspo ndin g values 
in th e contro l fibroblas t cultures w ere 6.0 ± 0.3 cpm/ ng . The 
ra ti o o f proal (1)/ proa2(1) mRN As in all cultu res w as approxi-
ma t e l y 2: 1, a nd consequently , the aSS JY of type I procoIlagcn 
mRN A levels utilizing either proal (I) o r proa2(1) specifi c cD NA 
pro b e ga ve the sa m e results afte r correctio n fo r chain compos ition 
of t y p e I procollagen . A relatively good overall correlatio n be-
rween the coll agen production and the type I procollagen mRNA 
level s was o bserved (Fig 1). 
The ratio of ty pe l!type III procollagen mRN As was also ex-
amine d b y hybridiza tions w ith proal (I) and proal (Ill) co llagen-
speci fic cDNA probes. This ratio in contro l fib roblas t cultures 
was 5 .9 ± 1.6 (mean ± SO) . A m ark edl y increased type I !II I 
pro c ollagen mRNA ratio was measured in the kelo id cell line 
studie d (patient no. 6), whereas slightly redu ced va lues were no ted 
in cases of m o rphea (patient n o. 2) and famili al cutaneous col-
lagen o m a (patient no . 4) (Fig 2). 
DISC U SSION 
In thi s study, w e have demonstrated that fibroblast cultures es-
tabli s h ed fro m a variet y o f fibro tic skin diseases display enhanced 
collagen production in vitro . This observa tion suggests, there-
Table III. Collagen Production in Fibro blast C ultures 
Es tablished Fro m Patients With C utaneous Fibrosis 
[3H]H ydroxyproline 
Patient" 
N o. 
1 
2 
3 
4 
5 
6 
Con trols' 
(dpml JLg protcin)" 
385.3 :± 24.9 
1351. 3 :± 359.8 
639.3 :± 146.3 
561. 2 :± 143 .1 
475 .8 :± 93.8 
465.2 ± 8. 1 
212.5 :± 80.7 
(% of control) 
181.3 
635.9 
300.8 
264. 1 
223.9 
218.9 
100.0 
"T he Ilum bers refe r to p"tients in Table II. 
"T he va lues arc expressed as dpm per J.Lg cell protein , lI1 ean ± SD of 3 para llel 
flasks. T he values in p:l tic ilts 1-6 arc statisticall y diffe ren t rro m the COlltro ls. p < 
0.05, as calculated by Aspin-Welch two-sample test of l1\e"ns. 
'The cont rols rep resen t no rmal fi bro blast culrll res w hich were cst:ablishcd fro m 
the site-matched skin of 5 age-matched control subjects and incubated parallel to 
the affected cell cultures under identical tissue culture conditions. 
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Figure 1. Correlation betwcen collagen production and type I procol-
lagen mRNA levels in fibroblast cultures established from patients with 
cuta neous fibroses. Collagen production was assayed by determination 
of newly synthesized 13H Jh ydroxyproline, expressed as dpm per JLg cell 
pro tein (sce Ta ble III). Type I procollagen mRNA levels were determined 
by hybridiza tions with proa2(1) collagen-specific cDNA probe, and the 
va lues were expressed as cpm per ng poly( A) + - RNA (see Resl/lts). The 
va lues in fib roblas t cultures from patients with cutaneous fi bros is (F) are 
expressed as percent (mean ± SEM) of the corresponding cont rols (C) 
which represent 6 paired normal fi broblast cultures examined under iden-
ti ca l culture conditions. 
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Figure 2. The ra tio of type 1/ 111 procollagcn mRN As in fib roblast cul-
tures es tablished from patients with cutaneous fibrosis or from site-matched 
skin of age-matched control subjects. The cul tures were incubated in a 
parallel manner under identical ti ssue culture conditions and examined at 
ea rl y visual conAuency. Poly(A) + -RN A was iso la ted by oligo-dT cel-
lulose chromatography and dotted on nitrocellulose fil ters in serial di-
lutions. Parallel fi lters were hybridized with human proa l (1) and proa l (1Il) 
co llagen cDN A probes. The limits of mean ± SD of 5 control cultu res 
arc indicated by the harched nren . The numbers by the values obtained 
with fi bro tic skin diseases (so lid circles) refer to patients in Table II . T he 
individual va lues arc the means of 2 separate experiments, each repre-
senting 6 parallel determinations with a va riation of < 18% (SD). 
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fo re, that the deposition of collagen, w hich can be demonstrated 
by histopathologic examination of the affected skin , results from 
increased synthesis of this protein in vivo. These observa tions are 
in agreement w ith prev ious demonstrations that the collagen pro-
ducti on by fi broblas t cul tures es tablished from patients w ith pro-
g ressive systemic sclerosis [9-1 2J, morphea [1 3]. and keloids 
[8, 14,15] is increased . 
Coll agen synthesis by human skin fibroblas ts is a process in-
vo lving several distin ct intracellul ar steps [31 ,32]. First, the 
expression of colla.gen gene is initiated by · transcription of th e 
in fo rm ation in D NA to a co rrespondin g mRNA precursor mol-
ecul e w hich, in addition to the codin g sequences (exons) , contains 
noncodin g sequences (introns) [32]. The precursor mRNA under-
goes several posttranscriptional m odifi ca tions, including removal 
of the introns by spli cing. Functi onal mRNA molecules then serve 
as template for the synthesis of proco ll agen po lypeptides. These 
polypeptides, pro-a chains, are extensively modifi ed by co- and 
posttranslational reactions w hich are enzy mati call y mediated [33]. 
U pon co mpletion of the intracellular events, the procollagen mol-
ecules are secreted into the extracellul ar space where they undergo 
fu rther modifica tions, including the rem oval of th e precursor-
specific extensions [31] . Thus, the produ ction of the extracellul ar 
coll agen m olecules could be controlled at several different levels 
of biosynthesis, either intracellularl y o r extracellul arly . 
In this study, we demonstrated that the increased procollagen 
production by cultured fibroblasts w as accompanied by a parallel 
increase in type I procollagen mRNA levels. This observation 
suggests then that procollagen produ ction in fibrobl as t cultures 
established from fibroti c skin diseases reflects eleva ted levels of 
the corres ponding procoll agen mRNA. The increased mRNA 
levels may result fro m enhanced transcriptional activity o f the 
corresponding genes [34]. or alternatively , increased stability as-
sociated with longer half-life o f the collagen mRN As could lead 
to accumulation of these m olecules [35]. N evertheless, the dem-
onstration of a correl ation between type I procollagen mRNA 
levels on one hand and the produ ction of the corresponding pro-
tein on the o ther, furth er supports previous suggestions [36,37] 
that a m aj o r contro l point in collagen production exists on the 
pretranslationallevel. These data also indicate that the differences 
in the rate of coll agen production between the fibroblasts from 
the fib ro tic diseases and the contro ls cannot be explained by al-
tered regulation on the posttranscriptional level [38]. 
Recent studies have clea rly established that collagens are a fam-
ily o f closely related yet genetically distinct proteins [39, 40]. The 
two m aj o r types o f procollagens synthesized by human skin fi-
broblas ts in culture are type I and type III [41,42]. In this study , 
we examined the relative expression of type I and type III pro-
collagen genes by measuring the corresponding mRNA levels. 
In control fibrobl as ts, the ratio o f type IIIII procollagen mRNAs 
was 5.9, a value which agrees with the ratio of type IIlII pro-
collagens synthesized by these cells in culture [42] . The ratio of 
type IIIlI procoll agen mRN A w as m arkedly elevated in patient 
no. 6 with kelo ids, sugges tin g that keloid fibrobl as ts may offer 
a unique model by which to study the independent regulation of 
gene expression o f two geneti ca ll y distin ct procoll agens [30]. In 
contras t to keloids, slightly reduced type IIIII procoll agen mRNA 
ratios were no ted in the fibrobl as ts from patients with morphea 
o r fa milial cutaneous collagenoma. It should be noted that type 
IIIII procollagen mRNA ratios w ere measured in patients' fibro-
blas t cultures which were incubated parallel to the contro l cell 
cultures under identical conditions. Thus, the altered collagen 
gene expression in fibroti c diseases may be selective in that one 
of the genetically di stin ct types of collagens is preferentially ex-
pressed. 
In summary , enhanced procollagen production w as demon-
strated in fibrobl as t cultures established from several patients with 
fibro tic skin diseases. A close correlation between the procoll agen 
produ ction and type I procollagen mRNA levels w as noted , sug-
gesting regulation on th e pretranslational level of procollagen 
gene expression . These observations furth er suggest that the ac-
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cumulation o f collagen in these conditions may result from en-
hanced synthesis o f this pro tein in vivo. It should be noted that 
the diseases examined in this study were representative only of 
som e of the distinct categories of derm al fibrosis. It is clear that 
m any of the categories wi thin the proposed classifi cation of the 
cutaneous diseases with dermal fibrosis (see T able I) are hetero-
geneous bo th clinically and biochemically . Furthermore, previous 
biochemi cal studies on collagen biosynthesis in a large number 
o f fibrobl as t cultures established from patients with keloids [8] 
o r progressive systemic sclerosis [11] have revealed considerable 
heterogeneity . Thus, the cell lines studied here may no t be ex-
clusively representative of the pheno typic expression within each 
diagnostic category, and it is conceivable that in o ther cases with 
fibro tic cutaneous diseases , additional facto rs, such as translation al 
and posttranslational control of pro tein synthesis or altered deg-
radative path way [1 9,43] m ay contribute to the excessive depo-
sition of collagen in the skin. 
Drs. Darwi/l J. Prockop ami Frall cesco Rall/irez, Unillersity of Medicille alld 
Detl tistry oJNew J erse y-RI/tgers Medica l Scll ool, colltribl/ted to til e developll/en t 
oj tile recoII/billallt D NA probes I/sed ill tllis stl/dy . Dr. A rt/,I/ r Z. Eisell, 
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